info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Superdisintegrants Market Size

ID: MRFR//5200-HCR | 100 Pages | Author: Rahul Gotadki| November 2024

The Pharmaceutical Superdisintegrants Market is a crucial part of the pharmaceutical industry, and it plays a central role in the production of oral dosage forms. They are substances added to pharma products with a view to enhancing their disintegration and dissolution so as to improve tablets decaying rates as well as drug availability. This market is growing fast because more people need medicines that dissolve easily and act quickly.

In pharmaceuticals, super-disintegrants primary roles are to speed up the breakdown of tablets or capsules into smaller particles on contact with water or saliva in order to facilitate quick drug release. This is particularly relevant when dealing with drugs that have low solubility or slow dissolution rates. The Pharmaceutical Superdisintegrants Market offers choices such as crospovidone and croscarmellose sodium (synthetic superdisintegrants), among others, for formulators looking for natural alternatives of disintegrating agents derived from plants.

The rising focus on patient compliance and convenience represents one of the key drivers in the Pharmaceutical Superdisintegrants Market. With fast-dissolving tablets like ODTs becoming more common, they offer user-friendly substitutes for traditional solid dosage forms. These formulations are mostly useful when patients cannot swallow tablets properly or water administration would be impractical during emergency treatment.

In response to efforts made by the pharmaceutical industry towards optimizing drug delivery and guaranteeing therapeutic efficacy of drugs, the market exists. Immediate-release formulations that enhance onset of action can be developed using superdisintegrants thus making them suitable for drugs requiring rapid absorption. For instance, this is vital during pain management or acute allergic reactions where there is necessity for immediate therapeutic responses.

Challenges within the Pharmaceutical Superdisintegrants Market include formulation compatibility issues with other components besides effects on drug stability. Other factors influencing choice range from physicochemical properties unique to each active substance, its release kinetics desired profile among others. The superdisintegrant options available allow drug developers to custom make their choices based on formulation considerations.

Ongoing research and development in the Pharmaceutical Superdisintegrants Market also target new superdisintegrants as well as enhanced existing formulations. Such studies have included natural superdisintegrants such as algae or starches, which are in line with the current trend in pharmaceutical industry of using environmentally friendly and sustainable materials.

Additionally, a growing number of paediatric and elderly patients often experience swallowing difficulties when taking conventional tablets hence market for these individuals is expanding. Superdisintegrants contribute to the development of age-appropriate formulations that enhance medication adherence and effectiveness in these patient groups.

Covered Aspects:

Report Attribute/Metric Details
Growth Rate   8.0%

Global Superdisintegrants Market Overview 


Superdisintegrants Market Size was valued at USD 3.73 Billion in 2023. The Global Superdisintegrants industry is projected to grow from USD 4.07 Billion in 2024 to USD 7.37 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.43% during the forecast period (2024 - 2032).


Superdisintegrants Market


Latest Industry Developments in Superdisintegrants Market

March 2024,Asahi Kasei has introduced a new superdisintegrant with enhanced swelling properties and improved disintegration efficiency, aiming to optimize tablet formulation and dissolution rates for better drug delivery by improving uniformity of disintegration.


May 2024,DFE Pharma has introduced a new cellulose-based superdisintegrant that enhances tablet mechanical strength and rapid disintegration, addressing challenges in high-dose formulations.


Disintegrants are chemicals added to medicine formulas to aid in the disintegration of capsules and tablets into easily dissolved particles. This is important for the rapid absorption of the medicine, which improves its potency. Superdisintegrants are disintegrants with small modifications that are more efficient than their standard equivalents. The pharmaceutical industry is rapidly expanding and has become an important aspect of the healthcare industry. This is mostly attributable to an increase in the number of geriatric and pediatric patients. 



Patients in this population benefit from super disintegrants because the tablets are simpler to swallow. These demographics are projected to drive market expansion. Furthermore, generic medications are in high demand since patents on some major prescription names have begun to expire, opening the pharmaceutical sector to increased competition and a rise in generic drug manufacturing, fuelling demand for superdisintegrants. Emerging markets provide enormous opportunities because their healthcare sectors are rapidly expanding. Furthermore, huge patient populations in these countries are projected to drive up the demand for fast-acting drugs. Market companies are likely to establish themselves in the region to take advantage of emerging market prospects.


Superdisintegrants Market Trends



MRFR's global superdisintegrants market report contains an entire historical analysis along with current trends to assemble a panoramic view of the market. Drivers, restraints, threats, and opportunities have been expounded in the report along with projections for the future of the market over the forecast period from 2024 to 2032. All parameters relevant to the global superdisintegrants market have been taken into account including the various parts of the market which have been segmented on the basis of types, formulation, therapeutic area, and region. Moreover, various key players operating in the market's competitive landscape have been profiled to provide an impact analysis of various vital growth strategies.


Key Companies in the superdisintegrants market include



  • Asahi Kasei Corporation

  • DFE Pharma

  • JRS Pharma

  • Corel Pharma Chem

  • Ashland Global Holdings Inc.

  • BASF SE

  • Roquette Freres

  • DowDuPont Inc.

  • Merck KGaA

  • Avantor Performance Materials, LLC


Research Methodology


Market Research Future's market report on the surface disinfectant market has employed various proprietary research methods to ascertain the forecast of the market. Primary data sources such as personal one-on-one interviews with marketing directors, and other important executives, thus providing a deeper insight into industry performance and expectations of the market. Meanwhile, secondary sources of data which refer to both internal and external sources such as customer feedback, analysis of marketing activities, industry publications, annual reports, and others are useful for a full commercial study of the global surface disinfectant market. Moreover, MRFR's data analysts use both top-down and bottom-up approaches for the estimation and validation of Superdisintegrants Market size. All data is processed, analyzed and consolidated into brief palatable reports which include intelligent observations regarding various important Superdisintegrants Market factors. 


Recent Development


Roquette built a new Pharmaceutical R&D and Customer Technical Service (CTS) in Biopolis (Singapore) in October 2017 for the development of new medicines, new applications for current products, and preclinical research. Roquette's Asia Pacific headquarters is located here, and it concentrates on food, nutrition, and pharmaceutical products. DFE Pharma's supply chain of pharmaceutical excipients was effectively streamlined in July 2018. Furthermore, the company has made significant investments in factory capacity development to address the global demand for high-quality excipients such as pharmaceutical grade Lactose and Microcrystalline Cellulose (MCC). Ashland launched a new pharmaceutical excipient factory in Nanjing, China, in October 2016, to create excipients for the Asian market. This laboratory provides highly functioning excipient technology to oral pharmaceutical makers as well as tailor-made formulation solutions.

Superdisintegrants Market Segmentation


Superdisintegrants Type Outlook



  • Synthetic Superdisintegrants

  • Natural Superdisintegrants

  • Other Superdisintegrants


Superdisintegrants Formulation Outlook



  • Tablets

  • Capsules


Superdisintegrants Therapeutic Area Outlook



  • Neurological Diseases

  • Gastrointestinal Diseases

  • Oncology

  • Inflammatory Diseases

  • Cardiovascular Diseases

  • Hematological Diseases

  • Infectious Diseases


Superdisintegrants Regional Outlook



  • Americas

  • Europe

  • Asia-Pacific

  • Middle East & Africa


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.